Abstract
Tubercidin represents one of the most widely recognized nucleosides isolated from natural sources. The major structural difference between adenosine and tubercidin is that one of the nitrogen atom is replaced by a C-H group in the heterocyclic base. Tubercidin was first introduced into the clinic over 40 years ago. Since then, there has been a steady interest and this review discusses the various approaches related to the synthesis of tubercidin and its derivatives. The key aspects related to isolation, structure-activity relationships and biological activity are also discussed.
Keywords: Tubercidin, natural product, nucleosides, antibiotic, synthesis.
Graphical Abstract
Current Organic Chemistry
Title:Tubercidin and Related Analogues: An Inspiration for 50 years in Drug Discovery
Volume: 20 Issue: 8
Author(s): Varughese A. Mulamoottil
Affiliation:
Keywords: Tubercidin, natural product, nucleosides, antibiotic, synthesis.
Abstract: Tubercidin represents one of the most widely recognized nucleosides isolated from natural sources. The major structural difference between adenosine and tubercidin is that one of the nitrogen atom is replaced by a C-H group in the heterocyclic base. Tubercidin was first introduced into the clinic over 40 years ago. Since then, there has been a steady interest and this review discusses the various approaches related to the synthesis of tubercidin and its derivatives. The key aspects related to isolation, structure-activity relationships and biological activity are also discussed.
Export Options
About this article
Cite this article as:
A. Mulamoottil Varughese, Tubercidin and Related Analogues: An Inspiration for 50 years in Drug Discovery, Current Organic Chemistry 2016; 20 (8) . https://dx.doi.org/10.2174/1385272819666150803231652
DOI https://dx.doi.org/10.2174/1385272819666150803231652 |
Print ISSN 1385-2728 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5348 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Pharmacogenetics and Drug Therapy in Psychiatry - The Role of the CYP2D6 Polymorphism
Current Pharmaceutical Design Polymorphisms at the LDLR Locus may be Associated with Ischemic Cerebrovascular Disease Independent of Lipid Profile
Current Neurovascular Research Ligand-Based Peptide Design and Combinatorial Peptide Libraries to Target G Protein-Coupled Receptors
Current Pharmaceutical Design Withdrawal Notice: Neuroprotective Effect of Lithospermum officinale callus Extract on Inflamed Primary Microglial Cells
Current Pharmaceutical Biotechnology Possible Involvement of Advanced Glycation End-Products (AGEs) in the Pathogenesis of Alzheimers Disease
Current Pharmaceutical Design Inflammation Drives Alzheimer's Disease: Emphasis on 5-lipoxygenase Pathways
Current Neuropharmacology Effect of Adding Proprioceptive Exercise to Balance Training in Older Adults with Diabetes: A Systematic Review
Current Diabetes Reviews Neuroprotection by NMDA Receptor Antagonists in a Variety of Neuropathologies
Current Drug Targets Key Role of Mitochondria in Alzheimer’s Disease Synaptic Dysfunction
Current Pharmaceutical Design Cognitive Identity in Schizophrenia: Vision, Space, and Body Perception from Prodrome to Syndrome
Current Psychiatry Reviews Nanomaterials for Improving the Properties of Polymeric Electrolyte Membranes in Energy Managing Devices
Nanoscience & Nanotechnology-Asia Philosophical Issues in the Prodromal Phase of Psychosis
Current Pharmaceutical Design The Role of Mitochondrial Impairment in Alzheimer´s Disease Neurodegeneration: The Tau Connection
Current Neuropharmacology GSTP1 Polymorphisms and their Association with Glutathione Transferase and Peroxidase Activities in Patients with Motor Neuron Disease
CNS & Neurological Disorders - Drug Targets Gamma-Amino Butyric Acid Inhibits the Nicotine-Imposed Stimulatory Challenge in Xenograft Models of Non-Small Cell Lung Carcinoma
Current Cancer Drug Targets Mechanisms of Action and Chemical-Biological Interactions Between Ozone and Body Compartments: A Critical Appraisal of the Different Administration Routes
Current Drug Therapy Editorial [Hot Topic: Protein Kinase Inhibitors for the Treatment of Inflammatory Disease (Guest Editor: Mark R. Player)]
Current Topics in Medicinal Chemistry Enteric Ecosystem Disruption in Autism Spectrum Disorder: Can the Microbiota and Macrobiota be Restored?
Current Pharmaceutical Design Macrophage Inflammatory Protein 1 and CCR5 as Attractive Therapeutic Targets for HIV Infection
Recent Patents on Anti-Infective Drug Discovery Design, Synthesis and Evaluation of Novel 2-piperidinyl Quinoline Chalcones/ Amines as Potential Antidepressant Agents
Letters in Drug Design & Discovery